AngioGenex, Inc. — Form D
AngioGenex, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2009-12-03. The offering totals $500K, of which $25K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-12-03
- Form: D
- Accession: 0001085596-09-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $500K
- Amount sold: $25K
- Remaining: $475K
- Minimum investment: $25K
- Investors: 1
- Date of first sale: 2009-11-16
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-136569
Issuer
- Name: AngioGenex, Inc.
- CIK: 0001085596
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 425 MADISON AVENUE, SUITE 902, NEW YORK, NY, 10017
- Phone: 646-642-0701
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| William Garland | Director | New York, NY |
| Richard Salvador | Director | New York, NY |
| William Garland | Executive Officer | New York, NY |
| Richard Salvador | Executive Officer | New York, NY |
| Martin Murray | Director | New York, NY |
| Martin Murray | Executive Officer | New York, NY |
| Michael Aronstein | Director | New York, NY |
| Michael Aronstein | Executive Officer | New York, NY |
| Michael Strage | Director | New York, NY |
| Michael Strage | Executive Officer | New York, NY |
Other filings by this issuer (1)
More